Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
-Legislation related to supply chain issues impacting medical devices -Legislation related to the reduction of opioid use and related addictions -S.586 and HR 3259: NO PAIN Act -S. 987 and HR 4341: Comprehensive Addiction and Recovery Act (CARA) 3.0
CARA 3.0 Act of 2021
Client: AVANOS MEDICAL, INC. (FKA HALYARD HEALTH, INC.) · Firm: POLSINELLI PC
-Legislation related to supply chain issues impacting medical devices -Legislation related to the reduction of opioid use and related addictions -S.586 and HR 3259: NO PAIN Act -S. 987 and HR 4341: Comprehensive Addiction and Recovery Act (CARA) 3.0
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
NEURIM PHARMACEUTICALS via POLSINELLI PC
2026 · third_quarter · Q3
Issues relating to FDA pharmaceutical regulations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AVANOS MEDICAL, INC. (FKA HALYARD HEALTH, INC.) via POLSINELLI PC
2026 · third_quarter · Q3
Source: Senate LDA
| FEMASYS INC |
| 4 |
| 2024 |
| BLUE EARTH DIAGNOSTICS INC | 3 | 2020 |
| MEDICAL GROUP CARE, LLC | 3 | 2023 |
| NEURIM PHARMACEUTICALS | 3 | 2026 |
| NEW DAY DIAGNOSTICS LLC | 3 | 2022 |
| CERAPEDICS, INC. | 2 | 2025 |
Issues related to FDAs authority to regulate products as drugs and medical devices: S 4348 FDASLA of 2022 HR 7667 Food and Drug Amendments 2022
Issues related to FDAs authority to regulate products as drugs and medical devices: S 4348 FDASLA of 2022 HR 7667 Food and Drug Amendments 2022 S 4333 The Clear Act FY 2023 Omnibus Appropriations Bill
Issues related to FDAs authority to regulate products as drugs and medical devices: S 4348 FDASLA of 2022 HR 7667 Food and Drug Amendments 2022 S 4333 The Clear Act
-Legislation related to the Covid-19 Pandemic and ventilator production -Legislation related to strengthening the supply chain -Issues related to readiness of Strategic National Stockpile -S.3799 PREVENT Pandemics Act
-Legislation related to the Covid-19 Pandemic and ventilator production -Legislation related to strengthening the supply chain -Issues related to readiness of Strategic National Stockpile -S.3799 PREVENT Pandemics Act
Issues related to FDAs authority to regulate products as drugs and medical devices: S 4348 FDASLA of 2022 HR 7667 Food and Drug Amendments 2022 S 4333 The Clear Act FY 2023 Omnibus Appropriations Bill
Issues related to FDAs authority to regulate products as drugs and medical devices: S 4348 FDASLA of 2022 HR 7667 Food and Drug Amendments 2022 S 4333 The Clear Act
Issues related to FDAs authority to regulate products as drugs and medical devices: S 4348 FDASLA of 2022 HR 7667 Food and Drug Amendments 2022
Issues related to FDAs authority to regulate products as drugs and medical devices: S 4348 FDASLA of 2022 HR 7667 Food and Drug Amendments 2022 S 4333 The Clear Act
Issues related to FDAs authority to regulate products as drugs and medical devices: S 4348 FDASLA of 2022 HR 7667 Food and Drug Amendments 2022 S 4333 The Clear Act FY 2023 Omnibus Appropriations Bill
-Legislation related to supply chain issues impacting medical devices -Legislation related to the reduction of opioid use and related addictions -S.586 and HR 3259: NO PAIN Act -S. 987 and HR 4341: Comprehensive Addiction and Recovery Act (CARA) 3.0
CARA 3.0 Act of 2021
Client: AVANOS MEDICAL, INC. (FKA HALYARD HEALTH, INC.) · Firm: POLSINELLI PC
-Legislation related to supply chain issues impacting medical devices -Legislation related to the reduction of opioid use and related addictions -S.586 and HR 3259: NO PAIN Act -S. 987 and HR 4341: Comprehensive Addiction and Recovery Act (CARA) 3.0
Legislation related to the reduction of opioid use and related addictions S.586 and HR 3259 NO PAIN Act S. 987-Comprehensive Addiction and Recovery Act (CARA) 3.0
-Legislation related to supply chain issues impacting medical devices -Legislation related to the reduction of opioid use and related addictions -S.586 and HR 3259: NO PAIN Act -S. 987 and HR 4341: Comprehensive Addiction and Recovery Act (CARA) 3.0
Legislation related to the reduction of opioid use and related addictions S.586 and HR 3259: NO PAIN Act S. 987 and HR 4341: Comprehensive Addiction and Recovery Act (CARA) 3.0
CARA 3.0 Act of 2021
Client: AVANOS MEDICAL, INC. (FKA HALYARD HEALTH, INC.) · Firm: POLSINELLI PC
-Legislation related to supply chain issues impacting medical devices -Legislation related to the reduction of opioid use and related addictions -S.586 and HR 3259: NO PAIN Act -S. 987 and HR 4341: Comprehensive Addiction and Recovery Act (CARA) 3.0
CARA 3.0 Act of 2021
Client: AVANOS MEDICAL, INC. (FKA HALYARD HEALTH, INC.) · Firm: POLSINELLI PC
Legislation related to the reduction of opioid use and related addictions S.586 and HR 3259: NO PAIN Act S. 987 and HR 4341: Comprehensive Addiction and Recovery Act (CARA) 3.0
-Legislation related to supply chain issues impacting medical devices -Legislation related to the reduction of opioid use and related addictions -S.586 and HR 3259: NO PAIN Act -S. 987 and HR 4341: Comprehensive Addiction and Recovery Act (CARA) 3.0
Legislation related to the reduction of opioid use and related addictions S.586 and HR 3259 NO PAIN Act S. 987-Comprehensive Addiction and Recovery Act (CARA) 3.0
Legislation related to the reduction of opioid use and related addictions S.586 and HR 3259: NO PAIN Act S. 987 and HR 4341: Comprehensive Addiction and Recovery Act (CARA) 3.0
Legislation related to the reduction of opioid use and related addictions S.586-NOPAIN Act S. 987-Comprehensive Addiction and Recovery Act (CARA) 3.0
CARA 3.0 Act of 2021
Client: AVANOS MEDICAL, INC. (FKA HALYARD HEALTH, INC.) · Firm: POLSINELLI PC
-Legislation related to supply chain issues impacting medical devices -Legislation related to the reduction of opioid use and related addictions -S.586 and HR 3259: NO PAIN Act -S. 987 and HR 4341: Comprehensive Addiction and Recovery Act (CARA) 3.0
CARA 3.0 Act of 2021
Client: AVANOS MEDICAL, INC. (FKA HALYARD HEALTH, INC.) · Firm: POLSINELLI PC
Legislation related to the reduction of opioid use and related addictions S.586 and HR 3259: NO PAIN Act S. 987 and HR 4341: Comprehensive Addiction and Recovery Act (CARA) 3.0
CARA 3.0 Act of 2021
Client: AVANOS MEDICAL, INC. (FKA HALYARD HEALTH, INC.) · Firm: POLSINELLI PC
Legislation related to the reduction of opioid use and related addictions S.586-NOPAIN Act S. 987-Comprehensive Addiction and Recovery Act (CARA) 3.0
CARA 3.0 Act of 2021
Client: AVANOS MEDICAL, INC. (FKA HALYARD HEALTH, INC.) · Firm: POLSINELLI PC
Legislation related to the reduction of opioid use and related addictions S.586 and HR 3259 NO PAIN Act S. 987-Comprehensive Addiction and Recovery Act (CARA) 3.0
Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019
Client: BLUE EARTH DIAGNOSTICS INC. · Firm: POLSINELLI PC
H.R. 3772 The Medicare Diagnostic Radiopharmaceutical Equity Act of 2019 CY 2020 Medicare Physician Fee Schedule Proposed Rule Legislation related to Cardiac PET Imaging
Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019
Client: BLUE EARTH DIAGNOSTICS INC. · Firm: POLSINELLI PC
H.R. 3772 The Medicare Diagnostic Radiopharmaceutical Equity Act of 2019 CY 2020 Medicare Physician Fee Schedule Proposed Rule Legislation related to Cardiac PET Imaging
Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019
Client: BRACCO DIAGNOSTICS, INC. · Firm: POLSINELLI PC
H.R. 3772 The Medicare Diagnostic Radiopharmaceutical Equity Act of 2019 CY 2020 Medicare Physician Fee Schedule Proposed Rule Legislation related to Cardiac PET Imaging
* Legislation related to the reduction of opioid use and related addictions * Implementation of HR 6, SUPPORT for Patients and Communities Act S 3067/HR 5172 Non-Opioid Prevention Addiction in the Nation Act
* Legislation related to the reduction of opioid use and related addictions * Implementation of HR 6, SUPPORT for Patients and Communities Act S 3067/HR 5172 Non-Opioid Prevention Addiction in the Nation Act
* Legislation related to the reduction of opioid use and related addictions * Implementation of HR 6, SUPPORT for Patients and Communities Act S 3067/HR 5172 Non-Opioid Prevention Addiction in the Nation Act
* Legislation related to the reduction of opioid use and related addictions * Implementation of HR 6, SUPPORT for Patients and Communities Act S 3067/HR 5172 Non-Opioid Prevention Addiction in the Nation Act
* Legislation related to the reduction of opioid use and related addictions * Implementation of HR 6, SUPPORT for Patients and Communities Act S 3067/HR 5172 Non-Opioid Prevention Addiction in the Nation Act
* Legislation related to the reduction of opioid use and related addictions * Implementation of HR 6, SUPPORT for Patients and Communities Act S 3067/HR 5172 Non-Opioid Prevention Addiction in the Nation Act
* Legislation related to the reduction of opioid use and related addictions * Implementation of HR 6, SUPPORT for Patients and Communities Act S 3067/HR 5172 Non-Opioid Prevention Addiction in the Nation Act
* Legislation related to the reduction of opioid use and related addictions * Implementation of HR 6, SUPPORT for Patients and Communities Act S 3067/HR 5172 Non-Opioid Prevention Addiction in the Nation Act
SUPPORT for Patients and Communities Act
Client: AVANOS MEDICAL, INC. (FKA HALYARD HEALTH, INC.) · Firm: POLSINELLI PC
* Legislation related to the reduction of opioid use and related addictions * Implementation of HR 6, SUPPORT for Patients and Communities Act S 3067/HR 5172 Non-Opioid Prevention Addiction in the Nation Act
SUPPORT for Patients and Communities Act
Client: AVANOS MEDICAL, INC. (FKA HALYARD HEALTH, INC.) · Firm: POLSINELLI PC
* Legislation related to the reduction of opioid use and related addictions * Implementation of HR 6, SUPPORT for Patients and Communities Act S 3067/HR 5172 Non-Opioid Prevention Addiction in the Nation Act
SUPPORT for Patients and Communities Act
Client: AVANOS MEDICAL, INC. (FKA HALYARD HEALTH, INC.) · Firm: POLSINELLI PC
* Legislation related to the reduction of opioid use and related addictions * Implementation of HR 6, SUPPORT for Patients and Communities Act S 3067/HR 5172 Non-Opioid Prevention Addiction in the Nation Act
SUPPORT for Patients and Communities Act
Client: AVANOS MEDICAL, INC. (FKA HALYARD HEALTH, INC.) · Firm: POLSINELLI PC
* Legislation related to the reduction of opioid use and related addictions * Implementation of HR 6, SUPPORT for Patients and Communities Act S 3067/HR 5172 Non-Opioid Prevention Addiction in the Nation Act
Protect Medical Innovation Act of 2019
Client: AVANOS MEDICAL, INC. (FKA HALYARD HEALTH, INC.) · Firm: POLSINELLI PC
* Legislation related to the reduction of opioid use and related addictions * Implementation of HR 6, SUPPORT for Patients and Communities Act * Medical Device Tax Repeal Legislation * S 692/HR 2207 Protect Medical Innovation Act of 2019 S 3067/HR 5172 Non-Opioid Prevention Addiction in the Nation Act
Protect Medical Innovation Act of 2019
Client: AVANOS MEDICAL, INC. (FKA HALYARD HEALTH, INC.) · Firm: POLSINELLI PC
* Legislation related to the reduction of opioid use and related addictions * Implementation of HR 6, SUPPORT for Patients and Communities Act * Medical Device Tax Repeal Legislation * S 692/HR 2207 Protect Medical Innovation Act of 2019
Competitive Bidding Program; Rural Rate Cut Issue; HR 2771 Protecting HOME Act of 2019
Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019
Client: BRACCO DIAGNOSTICS, INC. · Firm: POLSINELLI PC
H.R. 3772 The Medicare Diagnostic Radiopharmaceutical Equity Act of 2019 CY 2020 Medicare Physician Fee Schedule Proposed Rule Legislation related to Cardiac PET Imaging
Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019
Client: BRACCO DIAGNOSTICS, INC. · Firm: POLSINELLI PC
H.R. 3772 The Medicare Diagnostic Radiopharmaceutical Equity Act of 2019 CY 2020 Medicare Physician Fee Schedule Proposed Rule Legislation related to Cardiac PFT Imaging
* Legislation related to the reduction of opioid use and related addictions * Implementation of HR 6, SUPPORT for Patients and Communities Act * Medical Device Tax Repeal Legislation * S 692/HR 2207 Protect Medical Innovation Act of 2019 S 3067/HR 5172 Non-Opioid Prevention Addiction in the Nation Act
* Legislation related to the reduction of opioid use and related addictions * Implementation of HR 6, SUPPORT for Patients and Communities Act * Medical Device Tax Repeal Legislation * S 692/HR 2207 Protect Medical Innovation Act of 2019 S 3067/HR 5172 Non-Opioid Prevention Addiction in the Nation Act
Protect Medical Innovation Act of 2019
Client: AVANOS MEDICAL, INC. (FKA HALYARD HEALTH, INC.) · Firm: POLSINELLI PC
* Legislation related to the reduction of opioid use and related addictions * Implementation of HR 6, SUPPORT for Patients and Communities Act * Medical Device Tax Repeal Legislation * S 692/HR 2207 Protect Medical Innovation Act of 2019 S 3067/HR 5172 Non-Opioid Prevention Addiction in the Nation Act
Protect Medical Innovation Act of 2019
Client: AVANOS MEDICAL, INC. (FKA HALYARD HEALTH, INC.) · Firm: POLSINELLI PC
* Legislation related to the reduction of opioid use and related addictions * Implementation of HR 6, SUPPORT for Patients and Communities Act * Medical Device Tax Repeal Legislation * S 692/HR 2207 Protect Medical Innovation Act of 2019
SUPPORT for Patients and Communities Act
Client: AVANOS MEDICAL, INC. (FKA HALYARD HEALTH, INC.) · Firm: POLSINELLI PC
* Legislation related to the reduction of opioid use and related addictions * Implementation of HR 6, SUPPORT for Patients and Communities Act * Medical Device Tax Repeal Legislation * S 692/HR 2207 Protect Medical Innovation Act of 2019
SUPPORT for Patients and Communities Act
Client: AVANOS MEDICAL, INC. (FKA HALYARD HEALTH, INC.) · Firm: POLSINELLI PC
* Legislation related to the reduction of opioid use and related addictions * Implementation of HR 6, SUPPORT for Patients and Communities Act * Medical Device Tax Repeal Legislation * S 692/HR 2207 Protect Medical Innovation Act of 2019 S 3067/HR 5172 Non-Opioid Prevention Addiction in the Nation Act
SUPPORT for Patients and Communities Act
Client: AVANOS MEDICAL, INC. (FKA HALYARD HEALTH, INC.) · Firm: POLSINELLI PC
* Legislation related to the reduction of opioid use and related addictions * Implementation of HR 6, SUPPORT for Patients and Communities Act * Medical Device Tax Repeal Legislation
SUPPORT for Patients and Communities Act
Client: AVANOS MEDICAL, INC. (FKA HALYARD HEALTH, INC.) · Firm: POLSINELLI PC
* Legislation related to the reduction of opioid use and related addictions * Implementation of HR 6, SUPPORT for Patients and Communities Act * Medical Device Tax Repeal Legislation
Competitive Bidding Program; Rural Rate Cut issue HR 2445 DMEPOS Access and Transparency Act of 2017 HR 4229 Protecting HOME Access Act of 2017 Pending IFR, Durable Medical Equipment Fee Schedule, Adjustments to Resume the Transitional 50/50 Blended Rates to Provide Relief in Non-Competitive Bidding Areas (CMS-1687-IFC)
Competitive Bidding Program; Rural Rate Cut issue HR 2445 DMEPOS Access and Transparency Act of 2017 HR 4229 Protecting HOME Access Act of 2017 IFR, Durable Medical Equipment Fee Schedule, Adjustments to Resume the Transitional 50/50 Blended Rates to Provide Relief in Non-Competitive Bidding Areas (CMS-1687-IFC)
Competitive Bidding Program; Rural Rate Cut issue HR 2445 DMEPOS Access and Transparency Act of 2017 HR 4229 Protecting HOME Access Act of 2017 IFR, Durable Medical Equipment Fee Schedule, Adjustments to Resume the Transitional 50/50 Blended Rates to Provide Relief in Non-Competitive Bidding Areas (CMS-1687-IFC)
Competitive Bidding Program; Rural Rate Cut issue HR 2445 DMEPOS Access and Transparency Act of 2017 HR 4229 Protecting HOME Access Act of 2017 IFR, Durable Medical Equipment Fee Schedule, Adjustments to Resume the Transitional 50/50 Blended Rates to Provide Relief in Non-Competitive Bidding Areas (CMS-1687-IFC)
Competitive Bidding Program; Rural Rate Cut issue HR 2445 DMEPOS Access and Transparency Act of 2017 HR 4229 Protecting HOME Access Act of 2017 IFR, Durable Medical Equipment Fee Schedule, Adjustments to Resume the Transitional 50/50 Blended Rates to Provide Relief in Non-Competitive Bidding Areas (CMS-1687-IFC)
Competitive Bidding Program; Rural Rate Cut issue HR 2445 DMEPOS Access and Transparency Act of 2017 HR 4229 Protecting HOME Access Act of 2017 Pending IFR, Durable Medical Equipment Fee Schedule, Adjustments to Resume the Transitional 50/50 Blended Rates to Provide Relief in Non-Competitive Bidding Areas (CMS-1687-IFC)
Competitive Bidding Program; Rural Rate Cut issue HR 2445 DMEPOS Access and Transparency Act of 2017 HR 4229 Protecting HOME Access Act of 2017 IFR, Durable Medical Equipment Fee Schedule, Adjustments to Resume the Transitional 50/50 Blended Rates to Provide Relief in Non-Competitive Bidding Areas (CMS-1687-IFC)
Competitive Bidding Program; Rural Rate Cut issue HR 2445 DMEPOS Access and Transparency Act of 2017 HR 4229 Protecting HOME Access Act of 2017 IFR, Durable Medical Equipment Fee Schedule, Adjustments to Resume the Transitional 50/50 Blended Rates to Provide Relief in Non-Competitive Bidding Areas (CMS-1687-IFC)
To amend title XVIII of the Social Security Act to revise the NTAP period under the Medicare inpatient prospective payment system and the pass-through period under the Medicare outpatient prospective payment system.
Client: BRACCO DIAGNOSTICS, INC. · Firm: POLSINELLI PC
CY17 CMS HOPPS rule HR 4683 To amend title XVIII of the Social Security Act to revise the NTAP period under the Medicare inpatient prospective payment system and the pass-through period under the Medicare outpatient prospective payment system. FY18 Appropriations; Consolidated Appropriations Act 2018
Legislation related to the reduction of opioid use and related addictions HR 5776 Medicare and Opioid Safe Treatment Act HR 6 Support for Patients and Communities Act
Legislation related to the reduction of opioid use and related addictions HR 5776 Medicare and Opioid Safe Treatment Act HR 6 Support for Patients and Communities Act
Legislation related to the reduction of opioid use and related addictions. HR 5776 Medicare and Opioid Safe Treatment Act HR 6 21st Century Cures Act (Substance Use and Disorder Prevention that Promotes Opioid Recovery and Treatment)
SUPPORT for Patients and Communities Act
Client: AVANOS MEDICAL, INC. (FKA HALYARD HEALTH, INC.) · Firm: POLSINELLI PC
Legislation related to the reduction of opioid use and related addictions HR 5776 Medicare and Opioid Safe Treatment Act HR 6 Support for Patients and Communities Act
SUPPORT for Patients and Communities Act
Client: AVANOS MEDICAL, INC. (FKA HALYARD HEALTH, INC.) · Firm: POLSINELLI PC
Legislation related to the reduction of opioid use and related addictions HR 5776 Medicare and Opioid Safe Treatment Act HR 6 Support for Patients and Communities Act
21st Century Cures Act
Client: AVANOS MEDICAL, INC. (FKA HALYARD HEALTH, INC.) · Firm: POLSINELLI PC
Legislation related to the reduction of opioid use and related addictions. HR 5776 Medicare and Opioid Safe Treatment Act HR 6 21st Century Cures Act (Substance Use and Disorder Prevention that Promotes Opioid Recovery and Treatment)
Competitive Bidding Program HR 2445 DMEPOS Access and Transparency Act of 2017 HR 4229 Protecting HOME Access Act of 2017
Competitive Bidding Program HR 2445 DMEPOS Access and Transparency Act of 2017 HR 4229 Protecting HOME Access Act of 2017
To amend title XVIII of the Social Security Act to revise the NTAP period under the Medicare inpatient prospective payment system and the pass-through period under the Medicare outpatient prospective payment system.
Client: BRACCO DIAGNOSTICS, INC. · Firm: POLSINELLI PC
CY17 CMS HOPPS rule HR 4683 To amend title XVIII of the Social Security Act to revise the NTAP period under the Medicare inpatient prospective payment system and the pass-through period under the Medicare outpatient prospective payment system.
Administrations proposal to impose new tariffs
-Proposed Medicare coverage policies pertaining to pain management therapies -Renewal of the No Pain Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AVANOS MEDICAL, INC. (FKA HALYARD HEALTH, INC.) via POLSINELLI PC
2026 · second_quarter · 2A
Administrations proposal to impose new tariffs
Proposed Medicare coverage policies pertaining to pain management therapies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEURIM PHARMACEUTICALS via POLSINELLI PC
2026 · second_quarter · Q2
Issues relating to FDA pharmaceutical regulations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AVANOS MEDICAL, INC. (FKA HALYARD HEALTH, INC.) via POLSINELLI PC
2026 · second_quarter · Q2
Administrations proposal to impose new tariffs
Proposed Medicare coverage policies pertaining to pain management therapies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEURIM PHARMACEUTICALS via POLSINELLI PC
2026 · second_quarter · RR
Issues relating to FDA regulations relating to pharmaceuticals.
AVANOS MEDICAL, INC. (FKA HALYARD HEALTH, INC.) via POLSINELLI PC
2026 · first_quarter · Q1
Proposed Medicare coverage policies pertaining to pain management therapies
Administrations proposal to impose new tariffs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
CERAPEDICS, INC. via POLSINELLI PC
2025 · third_quarter · Q3
Issues related to the coverage, coding and reimbursement of products and services under Medicare
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES
2025 · third_quarter · Q3
FDA Regulatory Issues
CERAPEDICS, INC. via POLSINELLI PC
2025 · second_quarter · Q2
Issues related to the coverage, coding and reimbursement of products and services under Medicare
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES
2025 · second_quarter · Q2
FDA Regulatory Issues
Filing targets: HOUSE OF REPRESENTATIVES
AVANOS MEDICAL, INC. (FKA HALYARD HEALTH, INC.) via POLSINELLI PC
2025 · second_quarter · Q2
Federal programs pertaining to non-opioid pain management therapies
Administrations proposal to impose new tariffs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · first_quarter · Q1
FDA Regulatory Issues
Filing targets: HOUSE OF REPRESENTATIVES
AVANOS MEDICAL, INC. (FKA HALYARD HEALTH, INC.) via POLSINELLI PC
2025 · first_quarter · Q1
Federal programs pertaining to non-opioid pain management therapies
Administrations proposal to impose new tariffs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Q4
FDA Regulatory Issues
Filing targets: HOUSE OF REPRESENTATIVES
FEMASYS INC. via POLSINELLI PC
2024 · fourth_quarter · 4T
Issues related to Womens Health
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
AVANOS MEDICAL, INC. (FKA HALYARD HEALTH, INC.) via POLSINELLI PC
2024 · fourth_quarter · Q4
Administrations proposal to impose new tariffs.
Federal programs pertaining to non-opioid pain management therapies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Q3
FDA Regulatory Issues
Filing targets: HOUSE OF REPRESENTATIVES
FEMASYS INC. via POLSINELLI PC
2024 · third_quarter · Q3
Issues related to Womens Health
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
AVANOS MEDICAL, INC. (FKA HALYARD HEALTH, INC.) via POLSINELLI PC
2024 · third_quarter · Q3
Administrations proposal to impose new tariffs.
Federal programs pertaining to non-opioid pain management therapies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Q2
FDA Regulatory Issues
Filing targets: HOUSE OF REPRESENTATIVES
FEMASYS INC. via POLSINELLI PC
2024 · second_quarter · Q2
Issues related to Womens Health
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
AVANOS MEDICAL, INC. (FKA HALYARD HEALTH, INC.) via POLSINELLI PC
2024 · second_quarter · Q2
Federal programs pertaining to non-opioid pain management therapies
Administrations proposal to impose new tariffs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · RR
FDA Regulatory Issues
AVANOS MEDICAL, INC. (FKA HALYARD HEALTH, INC.) via POLSINELLI PC
2024 · first_quarter · Q1
Federal programs pertaining to non-opioid pain management therapies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FEMASYS INC. via POLSINELLI PC
2024 · first_quarter · RR
Issues related to women's health
MEDICAL GROUP CARE, LLC via POLSINELLI PC
2023 · second_quarter · 2T
Issues related to Health Care Issues related to NIH Funding
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
MEDICAL GROUP CARE, LLC via POLSINELLI PC
2023 · first_quarter · Q1
Issues related to Health Care Issues related to NIH Funding
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
MEDICAL GROUP CARE, LLC via POLSINELLI PC
2023 · first_quarter · RR
Issues related to health care.
NEW DAY DIAGNOSTICS LLC via POLSINELLI PC
2022 · fourth_quarter · 4T
Issues related to Covid
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRACCO DIAGNOSTICS, INC. via POLSINELLI PC
2022 · fourth_quarter · Q4
Issues related to FDAs authority to regulate products as drugs and medical devices: S 4348 FDASLA of 2022 HR 7667 Food and Drug Amendments 2022 S 4333 The Clear Act FY 2023 Omnibus Appropriations Bill
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES
NEW DAY DIAGNOSTICS LLC via POLSINELLI PC
2022 · third_quarter · Q3
Issues related to Covid
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRACCO DIAGNOSTICS, INC. via POLSINELLI PC
2022 · third_quarter · Q3
Issues related to FDAs authority to regulate products as drugs and medical devices: S 4348 FDASLA of 2022 HR 7667 Food and Drug Amendments 2022 S 4333 The Clear Act
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES
NEW DAY DIAGNOSTICS LLC via POLSINELLI PC
2022 · third_quarter · RR
- issues related to COVID
BRACCO DIAGNOSTICS, INC. via POLSINELLI PC
2022 · second_quarter · Q2
Issues related to FDAs authority to regulate products as drugs and medical devices: S 4348 FDASLA of 2022 HR 7667 Food and Drug Amendments 2022
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
VYAIRE MEDICAL, INC. via POLSINELLI PC
2022 · second_quarter · Q2
-Legislation related to the Covid-19 Pandemic and ventilator production -Legislation related to strengthening the supply chain -Issues related to readiness of Strategic National Stockpile -S.3799 PREVENT Pandemics Act
Filing targets: Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BRACCO DIAGNOSTICS, INC. via POLSINELLI PC
2022 · first_quarter · Q1
Issues related to FDAs authority to regulate products as drugs and medical devices
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
VYAIRE MEDICAL, INC. via POLSINELLI PC
2022 · first_quarter · Q1
-Legislation related to the Covid-19 Pandemic and ventilator production -Legislation related to strengthening the supply chain -Issues related to readiness of Strategic National Stockpile -S.3799 PREVENT Pandemics Act
Filing targets: Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AVANOS MEDICAL, INC. (FKA HALYARD HEALTH, INC.) via POLSINELLI PC
2022 · first_quarter · Q1
-Legislation related to supply chain issues impacting medical devices -Legislation related to the reduction of opioid use and related addictions -S.586 and HR 3259: NO PAIN Act -S. 987 and HR 4341: Comprehensive Addiction and Recovery Act (CARA) 3.0
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
BRACCO DIAGNOSTICS, INC. via POLSINELLI PC
2021 · fourth_quarter · Q4
Issues related to FDAs authority to regulate products as drugs and medical devices
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
VYAIRE MEDICAL, INC. via POLSINELLI PC
2021 · fourth_quarter · Q4
Legislation related to the Covid-19 Pandemic and ventilator production Legislation related to strengthening the supply chain Issues related to readiness of Strategic National Stockpile
Filing targets: Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AVANOS MEDICAL, INC. (FKA HALYARD HEALTH, INC.) via POLSINELLI PC
2021 · fourth_quarter · Q4
-Legislation related to supply chain issues impacting medical devices -Legislation related to the reduction of opioid use and related addictions -S.586 and HR 3259: NO PAIN Act -S. 987 and HR 4341: Comprehensive Addiction and Recovery Act (CARA) 3.0
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
BRACCO DIAGNOSTICS, INC. via POLSINELLI PC
2021 · fourth_quarter · RA
Issues related to FDA authority to regulate drugs and medical devices.
Issues related to FDA authority to regulate drugs and medical devices.
VYAIRE MEDICAL, INC. via POLSINELLI PC
2021 · third_quarter · Q3
Legislation related to the Covid-19 Pandemic and ventilator production Covid-19 Stimulus IV Package Legislation related to strengthening the supply chain Issues related to readiness of Strategic National Stockpile
Filing targets: Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AVANOS MEDICAL, INC. (FKA HALYARD HEALTH, INC.) via POLSINELLI PC
2021 · third_quarter · Q3
Legislation related to the reduction of opioid use and related addictions S.586 and HR 3259: NO PAIN Act S. 987 and HR 4341: Comprehensive Addiction and Recovery Act (CARA) 3.0
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
VYAIRE MEDICAL, INC. via POLSINELLI PC
2021 · second_quarter · Q2
Legislation related to the Covid-19 Pandemic and ventilator production Covid-19 Stimulus IV Package Legislation related to strengthening the supply chain Issues related to readiness of Strategic National Stockpile
Filing targets: Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AVANOS MEDICAL, INC. (FKA HALYARD HEALTH, INC.) via POLSINELLI PC
2021 · second_quarter · Q2
Legislation related to the reduction of opioid use and related addictions S.586 and HR 3259 NO PAIN Act S. 987-Comprehensive Addiction and Recovery Act (CARA) 3.0
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AVANOS MEDICAL, INC. (FKA HALYARD HEALTH, INC.) via POLSINELLI PC
2021 · first_quarter · Q1
Legislation related to the reduction of opioid use and related addictions S.586-NOPAIN Act S. 987-Comprehensive Addiction and Recovery Act (CARA) 3.0
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
VYAIRE MEDICAL, INC. via POLSINELLI PC
2021 · first_quarter · Q1
Legislation related to the Covid-19 Pandemic and ventilator production Covid-19 Stimulus IV Package Legislation related to strengthening the supply chain Issues related to readiness of Strategic National Stockpile
Filing targets: Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VYAIRE MEDICAL, INC. via POLSINELLI PC
2020 · fourth_quarter · Q4
Legislation related to the Covid-19 Pandemic and ventilator production Covid-19 Stimulus IV Package Legislation related to strengthening the supply chain Issues related to readiness of Strategic National Stockpile
Filing targets: Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Vice President of the U.S.
AVANOS MEDICAL, INC. (FKA HALYARD HEALTH, INC.) via POLSINELLI PC
2020 · fourth_quarter · Q4
* Legislation related to the reduction of opioid use and related addictions * Implementation of HR 6, SUPPORT for Patients and Communities Act S 3067/HR 5172 Non-Opioid Prevention Addiction in the Nation Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
VYAIRE MEDICAL, INC. via POLSINELLI PC
2020 · third_quarter · Q3
Legislation related to the Covid-19 Pandemic and ventilator production Covid-19 Stimulus IV Package Legislation related to strengthening the supply chain Issues related to readiness of Strategic National Stockpile
Filing targets: Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Vice President of the U.S.
AVANOS MEDICAL, INC. (FKA HALYARD HEALTH, INC.) via POLSINELLI PC
2020 · third_quarter · Q3
* Legislation related to the reduction of opioid use and related addictions * Implementation of HR 6, SUPPORT for Patients and Communities Act S 3067/HR 5172 Non-Opioid Prevention Addiction in the Nation Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
VYAIRE MEDICAL, INC. via POLSINELLI PC
2020 · second_quarter · Q2
Legislation related to the Covid-19 Pandemic and ventilator production Covid-19 Stimulus IV Package Legislation related to strengthening the supply chain
Filing targets: Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
AVANOS MEDICAL, INC. (FKA HALYARD HEALTH, INC.) via POLSINELLI PC
2020 · second_quarter · Q2
* Legislation related to the reduction of opioid use and related addictions * Implementation of HR 6, SUPPORT for Patients and Communities Act S 3067/HR 5172 Non-Opioid Prevention Addiction in the Nation Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
BLUE EARTH DIAGNOSTICS INC. via POLSINELLI PC
2020 · second_quarter · Q2
H.R. 3772 The Medicare Diagnostic Radiopharmaceutical Equity Act of 2019 CY 2020 Medicare Physician Fee Schedule Proposed Rule Legislation related to Cardiac PET Imaging
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
VYAIRE MEDICAL, INC. via POLSINELLI PC
2020 · first_quarter · Q1
Legislation related to the Covid-19 Pandemic and ventilator production Covid-19 Stimulus IV Package
Filing targets: Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
AVANOS MEDICAL, INC. (FKA HALYARD HEALTH, INC.) via POLSINELLI PC
2020 · first_quarter · Q1
* Legislation related to the reduction of opioid use and related addictions * Implementation of HR 6, SUPPORT for Patients and Communities Act S 3067/HR 5172 Non-Opioid Prevention Addiction in the Nation Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
BLUE EARTH DIAGNOSTICS INC. via POLSINELLI PC
2020 · first_quarter · Q1
H.R. 3772 The Medicare Diagnostic Radiopharmaceutical Equity Act of 2019 CY 2020 Medicare Physician Fee Schedule Proposed Rule Legislation related to Cardiac PET Imaging
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
BRACCO DIAGNOSTICS, INC. via POLSINELLI PC
2020 · first_quarter · 1T
H.R. 3772 The Medicare Diagnostic Radiopharmaceutical Equity Act of 2019 CY 2020 Medicare Physician Fee Schedule Proposed Rule Legislation related to Cardiac PET Imaging
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
BLUE EARTH DIAGNOSTICS INC. via POLSINELLI PC
2020 · first_quarter · RR
Legislation related to PET imaging
VYAIRE MEDICAL, INC. via POLSINELLI PC
2020 · first_quarter · RR
Issues related to the Covid-19 pandemic.
AVANOS MEDICAL, INC. (FKA HALYARD HEALTH, INC.) via POLSINELLI PC
2019 · fourth_quarter · Q4
* Legislation related to the reduction of opioid use and related addictions * Implementation of HR 6, SUPPORT for Patients and Communities Act * Medical Device Tax Repeal Legislation * S 692/HR 2207 Protect Medical Innovation Act of 2019 S 3067/HR 5172 Non-Opioid Prevention Addiction in the Nation Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
BRACCO DIAGNOSTICS, INC. via POLSINELLI PC
2019 · fourth_quarter · Q4
H.R. 3772 The Medicare Diagnostic Radiopharmaceutical Equity Act of 2019 CY 2020 Medicare Physician Fee Schedule Proposed Rule Legislation related to Cardiac PET Imaging
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AVANOS MEDICAL, INC. (FKA HALYARD HEALTH, INC.) via POLSINELLI PC
2019 · third_quarter · Q3
* Legislation related to the reduction of opioid use and related addictions * Implementation of HR 6, SUPPORT for Patients and Communities Act * Medical Device Tax Repeal Legislation * S 692/HR 2207 Protect Medical Innovation Act of 2019
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
BRACCO DIAGNOSTICS, INC. via POLSINELLI PC
2019 · third_quarter · Q3
H.R. 3772 The Medicare Diagnostic Radiopharmaceutical Equity Act of 2019 CY 2020 Medicare Physician Fee Schedule Proposed Rule Legislation related to Cardiac PFT Imaging
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KCI USA, INC. via POLSINELLI PC
2019 · third_quarter · 3T
Competitive Bidding Program; Rural Rate Cut Issue; HR 2771 Protecting HOME Act of 2019
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AVANOS MEDICAL, INC. (FKA HALYARD HEALTH, INC.) via POLSINELLI PC
2019 · second_quarter · Q2
* Legislation related to the reduction of opioid use and related addictions * Implementation of HR 6, SUPPORT for Patients and Communities Act * Medical Device Tax Repeal Legislation
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
KCI USA, INC. via POLSINELLI PC
2019 · second_quarter · Q2
Competitive Bidding Program; Rural Rate Cut Issue
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AVANOS MEDICAL, INC. (FKA HALYARD HEALTH, INC.) via POLSINELLI PC
2019 · first_quarter · Q1
* Legislation related to the reduction of opioid use and related addictions * Implementation of HR 6, SUPPORT for Patients and Communities Act * Medical Device Tax Repeal Legislation
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
BRACCO DIAGNOSTICS, INC. via POLSINELLI PC
2019 · first_quarter · Q1
Legislation related to FDA compliance matters
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
KCI USA, INC. via POLSINELLI PC
2019 · first_quarter · Q1
Competitive Bidding Program; Rural Rate Cut Issue
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AVANOS MEDICAL, INC. (FKA HALYARD HEALTH, INC.) via POLSINELLI PC
2018 · fourth_quarter · Q4
Legislation related to the reduction of opioid use and related addictions HR 5776 Medicare and Opioid Safe Treatment Act HR 6 Support for Patients and Communities Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
BRACCO DIAGNOSTICS, INC. via POLSINELLI PC
2018 · fourth_quarter · Q4
Issues relating to FDA compliance matters
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
KCI USA, INC. via POLSINELLI PC
2018 · fourth_quarter · Q4
Competitive Bidding Program; Rural Rate Cut issue HR 2445 DMEPOS Access and Transparency Act of 2017 HR 4229 Protecting HOME Access Act of 2017 IFR, Durable Medical Equipment Fee Schedule, Adjustments to Resume the Transitional 50/50 Blended Rates to Provide Relief in Non-Competitive Bidding Areas (CMS-1687-IFC)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AVANOS MEDICAL, INC. (FKA HALYARD HEALTH, INC.) via POLSINELLI PC
2018 · third_quarter · Q3
Legislation related to the reduction of opioid use and related addictions HR 5776 Medicare and Opioid Safe Treatment Act HR 6 Support for Patients and Communities Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRACCO DIAGNOSTICS, INC. via POLSINELLI PC
2018 · third_quarter · Q3
Issues relating to FDA compliance matters
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES
KCI USA, INC. via POLSINELLI PC
2018 · third_quarter · Q3
Competitive Bidding Program; Rural Rate Cut issue HR 2445 DMEPOS Access and Transparency Act of 2017 HR 4229 Protecting HOME Access Act of 2017 IFR, Durable Medical Equipment Fee Schedule, Adjustments to Resume the Transitional 50/50 Blended Rates to Provide Relief in Non-Competitive Bidding Areas (CMS-1687-IFC)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AVANOS MEDICAL, INC. (FKA HALYARD HEALTH, INC.) via POLSINELLI PC
2018 · second_quarter · Q2
Legislation related to the reduction of opioid use and related addictions. HR 5776 Medicare and Opioid Safe Treatment Act HR 6 21st Century Cures Act (Substance Use and Disorder Prevention that Promotes Opioid Recovery and Treatment)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KCI USA, INC. via POLSINELLI PC
2018 · second_quarter · Q2
Competitive Bidding Program; Rural Rate Cut issue HR 2445 DMEPOS Access and Transparency Act of 2017 HR 4229 Protecting HOME Access Act of 2017 IFR, Durable Medical Equipment Fee Schedule, Adjustments to Resume the Transitional 50/50 Blended Rates to Provide Relief in Non-Competitive Bidding Areas (CMS-1687-IFC)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AVANOS MEDICAL, INC. (FKA HALYARD HEALTH, INC.) via POLSINELLI PC
2018 · first_quarter · Q1
Legislation related to the reduction of opioid use and related addictions.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHADIA US INC. via POLSINELLI PC
2018 · first_quarter · 1T
Medicare and Medicaid coverage for allergy testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES
BRACCO DIAGNOSTICS, INC. via POLSINELLI PC
2018 · first_quarter · Q1
CY17 CMS HOPPS rule HR 4683 To amend title XVIII of the Social Security Act to revise the NTAP period under the Medicare inpatient prospective payment system and the pass-through period under the Medicare outpatient prospective payment system. FY18 Appropriations; Consolidated Appropriations Act 2018
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
KCI USA, INC. via POLSINELLI PC
2018 · first_quarter · Q1
Competitive Bidding Program; Rural Rate Cut issue HR 2445 DMEPOS Access and Transparency Act of 2017 HR 4229 Protecting HOME Access Act of 2017 Pending IFR, Durable Medical Equipment Fee Schedule, Adjustments to Resume the Transitional 50/50 Blended Rates to Provide Relief in Non-Competitive Bidding Areas (CMS-1687-IFC)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AVANOS MEDICAL, INC. (FKA HALYARD HEALTH, INC.) via POLSINELLI PC
2018 · first_quarter · RR
Help in the reduction of opioid use and related addiction.
BRACCO DIAGNOSTICS, INC. via POLSINELLI PC
2017 · fourth_quarter · Q4
CY17 CMS HOPPS rule HR 4683 To amend title XVIII of the Social Security Act to revise the NTAP period under the Medicare inpatient prospective payment system and the pass-through period under the Medicare outpatient prospective payment system.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PHADIA US INC. via POLSINELLI PC
2017 · fourth_quarter · Q4
Medicare and Medicaid coverage for allergy testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES
KCI USA, INC. via POLSINELLI PC
2017 · fourth_quarter · Q4
Competitive Bidding Program HR 2445 DMEPOS Access and Transparency Act of 2017 HR 4229 Protecting HOME Access Act of 2017
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
BRACCO DIAGNOSTICS, INC. via POLSINELLI PC
2017 · third_quarter · Q3
CY17 CMS HOPPS Rule
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PHADIA US INC. via POLSINELLI PC
2017 · third_quarter · Q3
Medicare and Medicaid coverage for allergy testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
KCI USA, INC. via POLSINELLI PC
2017 · third_quarter · Q3
- Competitive Bidding Program - DME Access and Stabilization Act - Patient Access to DME Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
BRACCO DIAGNOSTICS, INC. via POLSINELLI PC
2017 · second_quarter · Q2
CY17 CMS HOPPS Rule
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PHADIA US INC. via POLSINELLI PC
2017 · second_quarter · Q2
Medicare and Medicaid coverage for allergy testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
KCI USA, INC. via POLSINELLI PC
2017 · second_quarter · Q2
- Competitive Bidding Program - DME Access and Stabilization Act - Patient Access to DME Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
BRACCO DIAGNOSTICS, INC. via POLSINELLI PC
2017 · second_quarter · RR
CY 17 CMS HOPPS rule
KCI USA, INC. via POLSINELLI PC
2017 · second_quarter · RR
Competitive Bidding Program; DME Access and Stabilization Act; Patient Access to DME Act
PHADIA US INC. via POLSINELLI PC
2017 · second_quarter · RR
Medicare and Medicaid coverage for allergy testing.
Medicare and Medicaid coverage for allergy testing.